What are the causes of splenomegaly?

Causes of Enlarged Spleen

Splenomegaly results from five major pathophysiological mechanisms: infections, hematologic disorders, liver disease with portal hypertension, infiltrative/storage diseases, and malignancies. Understanding these categories helps systematically approach diagnosis and management, as the underlying cause directly impacts morbidity and mortality.

Primary Etiological Categories

1. Infectious Causes

Infections represent the most common cause of splenomegaly globally and in pediatric populations 1, 2:

• Viral infections: Infectious mononucleosis (Epstein-Barr virus), HIV, hepatitis B/C
• Bacterial infections: Enteric fever (typhoid), tuberculosis, bacterial endocarditis
• Parasitic infections: Malaria (most common worldwide cause), schistosomiasis (up to 80% prevalence in endemic tropical regions) 3, 4
• Granulomatous infections: Tuberculosis, histoplasmosis

In children, fever was the presenting symptom in 70% of cases with infectious splenomegaly 2.

2. Hematologic Disorders

These account for approximately 38% of pediatric cases and include both hemolytic and proliferative conditions 2:

• Hemolytic anemias: Sickle cell disease (particularly in children with acute splenic sequestration—a life-threatening emergency), thalassemias, hereditary spherocytosis, autoimmune hemolytic anemia 1, 5
• Myeloproliferative disorders: Myelofibrosis (can cause massive splenomegaly), polycythemia vera, essential thrombocythemia 6
• Lymphoproliferative disorders: Chronic lymphocytic leukemia, lymphomas, hairy cell leukemia 1
• Immune thrombocytopenia: Mild splenomegaly may occur in younger ITP patients, though moderate-to-massive splenomegaly suggests alternative diagnosis 7

3. Liver Disease and Portal Hypertension

Portal hypertension from any cause leads to congestive splenomegaly 8, 9:

• Cirrhosis: Alcoholic, viral hepatitis-related, non-alcoholic steatohepatitis, autoimmune hepatitis
• Portal vein thrombosis: Associated with hypercoagulable states, pancreatitis, inflammatory bowel disease
• Idiopathic non-cirrhotic portal hypertension (INCPH): Characterized by splenomegaly with normal liver function, often massive splenomegaly, and 40% prevalence of thrombophilic disorders in Western patients 8
• Splenic vein thrombosis: Secondary to pancreatitis, pancreatic cancer, hypercoagulable states 1

Critical pitfall: INCPH patients are frequently misdiagnosed as cirrhotic on imaging but have normal liver function tests and require liver biopsy for definitive diagnosis 8.

4. Infiltrative and Storage Diseases

Lysosomal storage diseases (LSDs) cause splenomegaly through accumulation of unmetabolized substrates 10, 11:

• Gaucher disease: Most common LSD causing splenomegaly; prevalence of 0.8% in unexplained splenomegaly cohorts 11
• Acid sphingomyelinase deficiency (ASMD/Niemann-Pick disease): Can cause massive splenomegaly (>10 times normal), often presenting in early childhood with hepatosplenomegaly, thrombocytopenia, and interstitial lung disease 10
• Lysosomal acid lipase deficiency (LALD)
• Other LSDs: GM1/GM2 gangliosidosis, Farber disease, mucopolysaccharidoses (typically milder splenomegaly) 10
• Sarcoidosis: Non-caseating granulomas 8, 1
• Amyloidosis

Overall, LSDs account for approximately 2% of unexplained splenomegaly cases 11.

5. Malignancies

• Primary splenic malignancies: Rare; include splenic lymphomas
• Metastatic disease: Uncommon but possible 1
• Leukemias: Acute and chronic forms

Diagnostic Approach Algorithm

When evaluating splenomegaly, proceed systematically:

Step 1: Confirm splenomegaly

• Physical examination (spleen palpable >2 cm below left costal margin)
• Abdominal ultrasonography for confirmation (spleen length ≥13 cm) 11, 3

Step 2: Assess for life-threatening complications

• Splenic sequestration in sickle cell disease (acute drop in hematocrit with shock risk) 1
• Splenic rupture risk (avoid contact sports) 3
• Massive splenomegaly with hypersplenism 5

Step 3: Initial laboratory evaluation

• Complete blood count with peripheral smear examination (essential—may reveal schistocytes, abnormal cells, cytopenias) 7, 3
• Liver function tests and transaminases 10
• Reticulocyte count (hemolysis assessment)
• Infectious workup based on exposure history: malaria smear, HIV, hepatitis serologies, EBV, blood cultures

Step 4: Imaging characterization

• CT abdomen/pelvis with IV contrast is most sensitive for detecting splenic pathology and complications (69% sensitivity for acute abnormalities) 1
• Assess for portal hypertension signs: varices, ascites, portosystemic collaterals 8, 9
• Evaluate liver parenchyma for cirrhosis vs. normal architecture

Step 5: Targeted testing based on initial findings

If portal hypertension suspected:

• Doppler ultrasound to confirm patent portal/hepatic veins 8
• Consider liver stiffness measurement (<12 kPa suggests INCPH rather than cirrhosis) 8
• Thrombophilia workup (40% prevalence in INCPH) 8

If hematologic disorder suspected:

• Bone marrow examination (particularly in patients >60 years, systemic symptoms, or pre-splenectomy evaluation) 7
• Flow cytometry and cytogenetics
• Hemoglobin electrophoresis for hemoglobinopathies

If storage disease suspected (especially with hepatosplenomegaly, cytopenias, bone pain, mixed dyslipidemia):

• Enzyme assays for Gaucher disease, ASMD 10, 11
• Genetic testing for LSDs

Step 6: Liver biopsy when indicated

• Essential for diagnosing INCPH (exclude cirrhosis, demonstrate phlebosclerosis) 8
• Required when chronic liver disease etiology unclear

Critical Clinical Pearls

Red flags requiring urgent evaluation:

• Fever with splenomegaly (infection, abscess, hematologic malignancy) 1
• Constitutional symptoms (weight loss, night sweats): suggest malignancy or chronic infection
• Moderate-to-massive splenomegaly in ITP: indicates alternative diagnosis 7
• Acute abdominal pain with splenomegaly: consider infarction, rupture, sequestration 1

Common diagnostic pitfalls:

• Assuming cirrhosis based on imaging alone in INCPH patients (requires biopsy confirmation) 8
• Missing LSDs in patients with "unexplained" splenomegaly and cytopenias (consider enzyme testing) 10, 11
• Overlooking thrombophilia workup in non-cirrhotic portal hypertension 8
• Failing to examine peripheral blood smear personally (pseudo-thrombocytopenia, abnormal cell morphology) 7

Geographic considerations: In tropical regions, malaria and schistosomiasis dominate (up to 80% prevalence), while in developed countries, liver disease, malignancy, and infection are most common 3, 4.

Post-splenectomy/hyposplenism management: All patients require vaccination against encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) starting ≥14 days post-procedure, annual influenza vaccination, and consideration of prophylactic antibiotics for at least 2 years due to overwhelming post-splenectomy infection (OPSI) risk of 0.5-2% with 30-70% mortality 12.